The proteomics market in North America is expected to show steady growth, driven by factors such as increasing R&D activities in pharmaceutical and biotechnology companies, technological advancements in proteomics research, and rising prevalence of chronic diseases. The United States and Canada are the key countries contributing to the growth of the proteomics market in North America.
Asia Pacific:
The proteomics market in Asia Pacific is projected to witness significant growth, attributed to factors such as increasing government funding for proteomics research, growing collaborations between research institutions and pharmaceutical companies, and rising demand for personalized medicine in countries like China, Japan, and South Korea.
Europe:
The proteomics market in Europe is anticipated to experience a robust growth, fueled by factors such as rising investments in healthcare infrastructure, growing adoption of proteomics technologies in diagnostic applications, and presence of key players in countries like the United Kingdom, Germany, and France.